Optimized ventricular restraint therapy: Adjustable restraint is superior to standard restraint in an ovine model of ischemic cardiomyopathy

Journal of Thoracic and Cardiovascular Surgery

Volumn 145, Issue 3, 2013, Pages 824-831

  Lee, Lawrence S ^a   Ghanta, Ravi K ^a   Mokashi, Suyog A ^a   Coelho Filho, Otavio ^a   Kwong, Raymond Y ^a   Kwon, Michael ^a   Guan, Jian ^a   Liao, Ronglih ^a   Chen, Frederick Y ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; GELATINASE A; POLYPROPYLENE;

ADJUSTABLE AND MEASURABLE VENTRICULAR RESTRAINT DEVICE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORONARY ARTERY LIGATION; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE SIZE; HEART OUTPUT; HEART STROKE VOLUME; HEART VENTRICLE REMODELING; ISCHEMIC CARDIOMYOPATHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSTHESIS MATERIAL; SHEEP; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT DURATION; VENTRICULAR ASSIST DEVICE; VENTRICULAR RESTRAINT THERAPY;

ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; HEART FAILURE; HEART FUNCTION TESTS; HEART VENTRICLES; LIGATION; MAGNETIC RESONANCE IMAGING; MATRIX METALLOPROTEINASE 2; NATRIURETIC PEPTIDE, BRAIN; SHEEP, DOMESTIC; VENTRICULAR REMODELING;

EID: 84873988139     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2012.05.018     Document Type: Article

References (19)

1. J.H. Oh, V. Badhwar, B.D. Mott, C.M. Li, and R.C. Chiu The effects of prosthetic cardiac binding and adynamic cardiomyoplasty in a model of dilated cardiomyopathy J Thorac Cardiovasc Surg 116 1998 148 153
2. W.F. Konertz, J.E. Shapland, H. Hotz, S. Dushe, J.P. Braun, and K. Stantke Passive containment and reverse remodeling by a novel textile cardiac support device Circulation 104 12 Suppl 1 2001 I270 I275
3. J.M. Power, J. Raman, A. Dornom, S.J. Farish, L.M. Burrell, and A.M. Tonkin Passive ventricular constraint amends the course of heart failure: a study in an ovine model of dilated cardiomyopathy Cardiovasc Res 44 1999 549 555
4. H.N. Sabbah, V.G. Sharov, R.C. Gupta, S. Mishra, S. Rastogi, and A.I. Undrovinas Reversal of chronic molecular and cellular abnormalities due to heart failure by passive mechanical ventricular containment Circ Res 93 2003 1095 1101
5. J.J. Pilla, A.S. Blom, D.J. Brockman, V.A. Ferrari, Q. Yuan, and M.A. Acker Passive ventricular constraint to improve left ventricular function and mechanics in an ovine model of heart failure secondary to acute myocardial infarction J Thorac Cardiovasc Surg 126 2003 1467 1476
6. A. Cheng, T.C. Nguyen, M. Malinowski, F. Langer, D. Liang, and G.T. Daughters Passive ventricular constraint prevents transmural shear strain progression in left ventricle remodeling Circulation 114 1 Suppl 2006 I79 I86
7. R.K. Ghanta, A. Rangaraj, R. Umakanthan, L. Lee, R.G. Laurence, and J.A. Fox Adjustable, physiological ventricular restraint improves left ventricular mechanics and reduces dilatation in an ovine model of chronic heart failure Circulation 115 2007 1201 1210
8. L.S. Lee, R.K. Ghanta, S.A. Mokashi, O. Coelho-Filho, R.Y. Kwong, and R.M. Bolman III Ventricular restraint therapy for heart failure: the right ventricle is different from the left ventricle J Thorac Cardiovasc Surg 139 2010 1012 1018
9. S.L. Moainie, J.H. Gorman 3rd, T.S. Guy, F.W. Bowen 3rd, B.M. Jackson, and T. Plappert An ovine model of postinfarction dilated cardiomyopathy Ann Thorac Surg 74 2002 753 760
10. M.C. Oz, W.J. Konertz, J. Raman, and F.X. Kleber Reverse remodeling of the failing ventricle: surgical intervention with the Acorn cardiac support device Congestive Heart Fail 10 2004 96 104
11. M.C. Oz, W.F. Konertz, F.X. Kelber, F.W. Mohr, J.F. Gummert, and J. Ostermeyer Global surgical experience with the Acorn cardiac support device J Thorac Carciovasc Surg 126 2003 983 991
12. C.T. Klodell Jr., D.C. McGiffin, B.K. Rayburn, B. Sun, W.T. Abraham, and J.V. Conte Initial United States experience with the Paracor HeartNet myocardial constraint device for heart failure J Thorac Cardiovasc Surg 133 2007 204 209
13. R.C. Starling, M. Jessup, J.K. Oh, H.N. Sabbah, M.A. Acker, and D.L. Mann Sustained benefits of the CorCap Cardiac Support Device on left ventricular remodeling: three year follow-up results from the Acorn clinical trial Ann Thorac Surg 84 2007 1236 1242
14. K. Chin, T. Nakamura, K. Shimizu, M. Mishima, T. Nakamura, and M. Miyasaka Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome Am J Med 109 2000 562 567
15. J.A. Dixon, A.M. Goodman, W.F. Gaillard, W.T. Rivers, R.A. McKinney, and R. Mukherjee Hemodynamics and myocardial blood flow patterns after placement of a cardiac passive restraint device in a model of dilated cardiomyopathy J Thorac Cardiovasc Surg 142 2011 1038 1045
16. L.E. Rohde, A. Ducharme, L.H. Arroyo, M. Aikawa, G.H. Sukhova, and A. Lopez-Anaya Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice Circulation 99 1999 3063 3070
17. T. Yamazaki, J.D. Lee, H. Shimizu, H. Uzui, and T. Ueda Circulating matrix metalloproteinase-2 is elevated in patients with congestive heart failure Eur J Heart Fail 6 2004 41 45
18. A. Shirakabe, K. Asai, N. Hata, S. Yokoyama, T. Shinada, and N. Kabayashi Prognostic impact of matrix metalloproteinases in patients with acute heart failure J Am Coll Cardiol 55 2010 A34.E330
19. E. Creemers, J. Cleutjens, J. Smits, and M. Daemen Matrix metalloproteinase inhibition after myocardial infarction. A new approach to prevent heart failure? Circ Res 89 2001 201 210